Nell S. Lurain - Concepedia

Author

Nell S. Lurain

Rush University Medical Center ORCID

Also Known As

N Lurain, N S Lurain, N. Lurain, N. S. Lurain, N.S. Lurain, Nell Lurain, Nell S Lurain, Nell S. Lurain, Nell S. Lurain

Publications

5.6K

Citations

H-Index

Concepts

All Affiliations

Rush University Medical Center Rush University Presbyterian St. Luke's Medical Center Cleveland Clinic Loyola University Medical Center

About

Nell S. Lurain is an author at Rush University Medical Center specializing in medicine, virology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	20	1.8K
2	Natural Sciences	3	3	475
3	Engineering	1	1	53
4	Health Sciences	1	1	85
5	Allergy	1	1	41

Nell S. Lurain

Publications

4.9K

Citations

H-Index

Page 1

	Year	Citations
T Cell Activation and Senescence Predict Subclinical Carotid Artery Disease in HIV-Infected Women Robert C. Kaplan, Elizabeth Sinclair, Alan Landay, The Journal of Infectious Diseases	2011	284
Evolutionarily divergent herpesviruses modulate T cell activation by targeting the herpesvirus entry mediator cosignaling pathway Timothy C. Cheung, Ian R. Humphreys, Karen G. Potter, Proceedings of the National Academy of Sciences	2005	203
Viral DNA Polymerase Mutations Associated with Drug Resistance in Human Cytomegalovirus Sunwen Chou, Nell S. Lurain, Kim D. Thompson, The Journal of Infectious Diseases Viral ReplicationMedicineNatural SciencesImmunologyMolecular Biology	2003	196
Cutting Edge: A Novel Viral TNF Receptor Superfamily Member in Virulent Strains of Human Cytomegalovirus Chris A. Benedict, Kris D. Butrovich, Nell S. Lurain, The Journal of Immunology	1999	179
Host cell-derived complement control proteins CD55 and CD59 are incorporated into the virions of two unrelated enveloped viruses. Human T cell leukemia/lymphoma virus type I (HTLV-I) and human cytomegalovirus (HCMV) Gregory T. Spear, Nell S. Lurain, CJ Parker, The Journal of Immunology	1995	168
Artesunate as a Potent Antiviral Agent in a Patient with Late Drug‐Resistant Cytomegalovirus Infection after Hematopoietic Stem Cell Transplantation Michael Y. Shapira, Igor Resnick, Sunwen Chou, Clinical Infectious Diseases Cytomegalovirus InfectionTransplantationViral PersistenceHematologyAntiviral Response	2008	154
Virological and Immunological Characteristics of Human Cytomegalovirus Infection Associated With Alzheimer Disease Nell S. Lurain, Barbara A. Hanson, Jeffrey Martinson, The Journal of Infectious Diseases	2013	153
A Standardized Plaque Reduction Assay for Determination of Drug Susceptibilities of Cytomegalovirus Clinical Isolates Marie L. Landry, Sylvia C. Stanat, Karen K. Biron, Antimicrobial Agents and Chemotherapy	2000	148
NOVEL MECHANISM OF INHIBITION OF CYTOMEGALOVIRUS BY THE EXPERIMENTAL IMMUNOSUPPRESSIVE AGENT LEFLUNOMIDE1,2 W. James Waldman, Deborah A. Knight, Nell S. Lurain, Transplantation	1999	143
Inhibition of Cytomegalovirus in vitro and in vivo by the Experimental Immunosuppressive Agent Leflunomide W. James Waldman, Deborah A. Knight, Leonard Blinder, Intervirology Endothelial CellsMedicineImmunosuppressive TherapyCmv DiseaseImmunology	1999	142

Page 1